Fundamental Analysis of Roivant Sciences Ltd - Growth / Value Index
ROIV - Valuation Highlights
Valuation Analysis
Price to Earning Ratio is 1.99 and EV to EBITDA is -10.01 suggesting company is undervalued.
Book Value in last 3 years is trending down
Valuation Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ |
---|---|---|---|---|
Price to Earning | 1.97 | -6.51 | 26.87 % | |
Price to Book | 3.58 | 4.98 | 36.47 % | 1.44 |
Price to Sales | 88.34 | 285.77 | 110.06 % | |
Enterprise Value to EBITDA Multiple | -9.91 | -5.75 | 14.53 % |
ROIV - Profitability Highlights
Profitability Analysis
Earning Yield of 50.31 %
During the past twelve months, the company has given a strong Return On Equity of 221.94%
During the past twelve months, the company has given a strong Return On Asset of 138.64%
During the past twelve months, the company has given a strong Net Margin of 4484.41%
Piotroski F Score - Very Poor Value of 1.0
Very Low Dividend Yield of 0 %
Negative Net profit for last two years
In the last three years, the company has given poor Returns on Equity
In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ |
---|---|---|---|---|
Return On Equity | 221.94 | -106.24 | -108.26 % | 83.68 |
Return On Asset | 138.64 | -51.47 | -57.43 % | 69.69 |
Net Profit Margin | 4484.41 | -4391.22 | -187.22 % | 13721.55 |
Operating Profit Margin | 4291.06 | -3483.89 | -42.50 % | 13626.50 |
EBITDA Margin | -790.25 | -4195.92 | -174.56 % | -605.22 |
Highlights
Market Cap | 9049.65 M |
Enterprise Value | 7800.77 M |
Price/Book TTM | 3.58 |
Outstanding Share | 805846 K |
Float/ Outstanding Share | 52.29% |
Dividend Yield | 0 % |
Share Holding
Guru Numbers
Price/Graham No | 0.660 |
Peter Lynch Ratio | 0 |
Piotroski F Score | 1.00 |
Altman Z Score | 3.86 |
Sloan Ratio | -0.143 |
Peter Lynch Fair Value | 0 |
ROIV - Growth Highlights
Growth Analysis
YoY Net Margin Jump by 187.22%
Quarterly sales in last 5 years is trending up
Tsr Growth Index - Very Poor Score of 11.36
Companies' sales dropped by 49.33 % from last year
Company's Total Assets is Decreasing for last 3 years
Operating Cash Flow decreasing for last 3 year
Growth Key Fields
Field | TTM | YoY Growth | QoQ Growth |
---|---|---|---|
Revenue | 99599.00 K | 49.33 % | 101.58 % |
Gross Profit | 88451.00 K | 67.87 % | 120.82 % |
EBITDA | -787086.00 K | 39.11 % | 18.69 % |
Net Profit | 4466.42 M | 45.52 % | 1774.58 % |
EPS | 5.70 | 36.73 % | NA |
ROIV - Stability Highlights
Stability Analysis
Altman Z Score of 3.92 suggests good Stability
Cash ratio of 6.15
Tsr Stability Index - Poor Score of 28.12
Company is unable to generate enough free cash to support the business.
Interest Coverage of -42.70
Stability Key Ratios
Ratio | Latest FY | Yoy Change | MRQ |
---|---|---|---|
Debt to Equity Ratio | 0.370 | 176.59 % | 0.075 |
Cash Ratio | 6.15 | -44.93 % | |
Quick Ratio | 6.59 | -43.82 % | 27.77 |
Shareholders Equity | 48.45 | -24.41 % | |
Debt to EBITDA | -0.364 | -38.93 % |
Historical Valuation Ratios of Roivant Sciences Ltd
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Roivant Sciences Ltd
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Roivant Sciences Ltd
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Roivant Sciences Ltd
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)